Research Disease Areas
We focus on discovering and advancing new treatments for serious patient needs. From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
Immuno-oncology
Our Immuno-oncology research program aims to treat most human cancers with immune therapy.
Oncology
Our Oncology group explores mechanisms and potential therapeutics for a wide range of both common and rare cancers.
Neuroscience
Learn how our recent advances in model systems and technology help us pursue revolutionary therapies for neurodegenerative, neurodevelopmental and neuropsychiatric conditions.
Cardiovascular & Metabolic Diseases
Concentrates on dyslipidemia, atherosclerosis and vascular diseases, type 2 diabetes, heart failure, cardiac arrhythmias and associated disorders.
Autoimmunity, Transplantation & Inflammatory Disease
Pioneers novel therapeutic modalities for the treatment of rheumatic and dermatological diseases as well as other auto-immune and inflammatory conditions.
Musculoskeletal Diseases
The musculoskeletal disease research team focuses on discovering therapies for muscle wasting and bone disorders.
Ophthalmology
The ophthalmology team at NIBR is working on new scientific discoveries for eye disorders including age-related macular degeneration.
Respiratory Diseases
The respiratory research team focuses on the discovery and development of novel therapies for a broad range of respiratory diseases, from common to rare (genetic) diseases such as cystic fibrosis.
Tropical Diseases
The Novartis Institute for Tropical Diseases is a drug discovery research institute dedicated to finding novel treatments for neglected tropical diseases, including malaria, cryptosporidiosis, and three major kinetoplastid diseases – human African trypanosomiasis, Chagas disease, and leishmaniasis.